Loading…
Based on limited metadata, the FDA issued a warning letter to Fatima Brothers on April 7, 2020, regarding an unspecified product category. Without access to the full letter text or detailed subject information, the specific nature of the regulatory violations cannot be determined from the available metadata. The warning pertains to products under FDA jurisdiction, though the issuing office and exact violation count are not documented in the provided information. A review of the complete warning letter would be necessary to identify the specific compliance issues and regulatory requirements involved.